[News Brief] MicroPort CardioFlow Launches LBBOT Solution in Europe, Australia

MicroPort CardioFlow Launches LBBOT Solution in Europe, Australia

MicroPort CardioFlow has announced the commercial launch of its LBBOT Solution in Europe and Australia following applicable regulatory clearances, introducing a portable ECG system designed to support physiological pacing procedures.

  • System features: The solution includes a Smart ECG device, Hookup Smart Software and an RC115 cable, enabling continuous 12-lead ECG monitoring and automated ventricular activation timing measurements.
  • Connectivity: The system uses Bluetooth-enabled connectivity and a compact architecture to support use across electrophysiology laboratories, operating rooms and outpatient centres.
  • Clinical evaluation: A multicentre study in France and Spain enrolled 55 patients and completed recruitment in April 2026 to assess system use and device handling during LBBAP procedures.

This summary is based on a press release issued by MicroPort CardioFlow.

Image for illustrative purposes only. Source: Canva.

About Ehub365

For Corporate Clients, ehub365 division delivers critical insights into the ASEAN medical sector, covering investments, new services, and practitioner news. 

A member of 365Asia. Our additional group services are Health365, 365Asia, 健康365, 365Sehat, and 365MEC.

scroll to top